A. De-biomédecine, Le rapport médical et scientifique du prélèvement et de la greffe en France, 2016.

A. Bacigalupo, K. Ballen, D. Rizzo, S. Giralt, H. Lazarus et al., Defining the intensity of conditioning regimens: working definitions, Biol Blood Marrow Transplant, vol.15, pp.1628-1661, 2009.

A. Gupta, S. Punatar, L. Mathew, S. Kannan, and N. Khattry, Cyclosporine Plus Methotrexate or Cyclosporine Plus Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Acute Leukemia Transplant: Comparison of Toxicity, Engraftment Kinetics and Transplant Outcome, Indian J Hematol Blood Transfus, vol.32, pp.248-56, 2016.

R. Ram, A. Gafter-gvili, M. Yeshurun, M. Paul, P. Raanani et al., Prophylaxis regimens for GVHD: systematic review and meta-analysis, Bone Marrow Transplant, vol.43, pp.643-53, 2009.

I. Helal, A. Byzun, J. P. Rerolle, E. Morelon, H. Kreis et al., Acute renal failure following allogeneic hematopoietic cell transplantation: incidence, outcome and risk factors, Saudi J Kidney Dis Transpl, vol.22, pp.437-480, 2011.

J. A. Lopes, J. S. Gonçalves, S. Resina, C. Silva, S. De-almeida et al., Contemporary analysis of the influence of acute kidney injury (AKI) after myeloablative hematopoietic cell transplantation on long-term patient's survival, Bone Marrow Transplant, vol.42, pp.139-180, 2008.

N. Shingai, T. Morito, Y. Najima, T. Kobayashi, N. Doki et al., Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients, Bone Marrow Transplant, vol.50, pp.1557-62, 2015.

J. Mori, K. Ohashi, T. Yamaguchi, M. Ando, Y. Hirashima et al., Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria, Intern Med, vol.51, pp.2105-2115, 2012.

Z. Yu, J. Ding, B. Chen, B. Liu, H. Liu et al., Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation, Chin J Cancer, vol.29, pp.946-51, 2010.

C. R. Parikh, P. A. Mcsweeney, D. Korular, T. Ecder, A. Merouani et al., Renal dysfunction in allogeneic hematopoietic cell transplantation, Kidney Int, vol.62, pp.566-73, 2002.

E. Gruss, C. Bernis, J. F. Tomas, C. Garcia-canton, A. Figuera et al., Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome, Am J Nephrol, vol.15, pp.473-482, 1995.

Y. Kagoya, K. Kataoka, Y. Nannya, and M. Kurokawa, Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation, Biol Blood Marrow Transplant, vol.17, pp.394-400, 2011.

V. Krishnappa, M. Gupta, G. Manu, S. Kwatra, O. Owusu et al., Acute Kidney Injury in Hematopoietic Stem Cell Transplantation: A Review, Int J Nephrol, p.5163789, 2016.

D. Jagu?, K. Lis, L. Niemczyk, and G. W. Basak, Kidney dysfunction after hematopoietic cell transplantation-Etiology, management, and perspectives, Hematol Oncol Stem Cell Ther, 2018.

S. Hingorani, Renal Complications of Hematopoietic-Cell Transplantation, N Engl J Med, vol.374, pp.2256-67, 2016.

F. Saddadi, I. Najafi, M. S. Hakemi, K. Falaknazi, F. Attari et al., Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran, Iran J Kidney Dis, vol.4, pp.20-26, 2010.

B. Sehgal, P. George, M. J. John, and C. Samuel, Acute kidney injury and mortality in hematopoietic stem cell transplantation: A single-center experience, Indian J Nephrol, vol.27, pp.13-22, 2017.

N. Nishio, H. Yagasaki, Y. Takahashi, A. Hama, H. Muramatsu et al., Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children, Pediatr Transplant, vol.13, pp.831-838, 2009.

Y. Liu, L. Xu, X. Zhang, Y. Wang, K. Liu et al., Acute kidney injury following haplo stem cell transplantation: incidence, risk factors and outcome, Bone Marrow Transplant, vol.53, pp.483-489, 2018.

D. A. Holt, J. T. Sinnott, R. L. Oehler, E. A. Bradley, and . Bk, Infect Control Hosp Epidemiol, vol.13, pp.738-779, 1992.

A. Baldwin, H. Kingman, M. Darville, A. B. Foot, D. Grier et al., Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation, Bone Marrow Transplant, vol.26, pp.1333-1341, 2000.

J. L. Piñana, A. Perez-pitarch, I. Garcia-cadenas, P. Barba, J. C. Hernandez-boluda et al., A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus-and Sirolimus-based Graft-versus-Host Disease Prophylaxis, Biol Blood Marrow Transplant, vol.23, pp.1177-85, 2017.

P. Satwani, S. Bavishi, J. Z. Jacobson, J. S. Baker, C. Duffy et al., Risk factors associated with kidney injury and the impact of kidney injury on overall survival in pediatric recipients following allogeneic stem cell transplant, Biol Blood Marrow Transplant, vol.17, pp.1472-80, 2011.

T. Shimoi, M. Ando, W. Munakata, T. Kobayashi, K. Kakihana et al., The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT, Bone Marrow Transplant, vol.48, pp.80-84, 2013.

B. N. Savani, S. Mielke, K. Rezvani, A. Montero, A. S. Yong et al., Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T celldepleted allogeneic stem cell transplantation, Biol Blood Marrow Transplant, vol.13, pp.1216-1239, 2007.
DOI : 10.1016/j.bbmt.2007.07.005

URL : https://doi.org/10.1016/j.bbmt.2007.07.005

D. H. Kim, J. G. Kim, S. K. Sohn, W. J. Sung, J. S. Suh et al., Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation, Br J Haematol, vol.125, pp.217-241, 2004.
DOI : 10.1111/j.1365-2141.2004.04891.x

J. Ogonek, K. Juric, M. Ghimire, S. Varanasi, P. R. Holler et al., Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol, vol.7, p.507, 2016.

J. Storek, Immunological reconstitution after hematopoietic cell transplantation -its relation to the contents of the graft, Expert Opin Biol Ther, vol.8, pp.583-97, 2008.

, Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials, Stem Cell Trialists' Collaborative Group, vol.23, pp.5074-87, 2005.

T. L. Gonçalves, D. M. Benvegnú, and G. Bonfanti, Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation, Oxid Med Cell Longev, vol.2, pp.82-89, 2009.

S. Agrawal, P. Gollapudi, R. Elahimehr, M. V. Pahl, and N. D. Vaziri, Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production, Nephrol Dial Transplant, vol.25, pp.737-783, 2010.

W. H. Lim, S. Kireta, E. Leedham, G. R. Russ, and P. T. Coates, Uremia impairs monocyte and monocytederived dendritic cell function in hemodialysis patients, Kidney Int, vol.72, pp.1138-1186, 2007.
DOI : 10.1038/sj.ki.5002425

URL : https://doi.org/10.1038/sj.ki.5002425

M. A. Verkade, C. J. Van-druningen, O. De-hoek, C. T. Weimar, W. Betjes et al., Decreased antigenspecific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis, Clin Exp Med, vol.7, pp.65-71, 2007.
DOI : 10.1007/s10238-007-0127-x

URL : https://link.springer.com/content/pdf/10.1007%2Fs10238-007-0127-x.pdf

H. Vacher-coponat, C. Brunet, L. Lyonnet, E. Bonnet, A. Loundou et al., Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients, Nephrol Dial Transplant, vol.23, pp.1406-1420, 2008.

M. V. Pahl, S. Gollapudi, L. Sepassi, P. Gollapudi, R. Elahimehr et al., Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression, Nephrol Dial Transplant, vol.25, pp.205-217, 2010.
DOI : 10.1093/ndt/gfp397

URL : https://academic.oup.com/ndt/article-pdf/25/1/205/7632763/gfp397.pdf

G. Fernández-fresnedo, M. A. Ramos, M. C. González-pardo, A. L. De-francisco, M. López-hoyos et al., B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2, Nephrol Dial Transplant, vol.15, pp.502-512, 2000.

J. Yoon, S. Gollapudi, M. V. Pahl, and N. D. Vaziri, Naïve and central memory T-cell lymphopenia in end-stage renal disease, Kidney Int, vol.70, pp.371-377, 2006.
DOI : 10.1038/sj.ki.5001550

URL : https://doi.org/10.1038/sj.ki.5001550

M. Betjes, A. W. Langerak, A. Van-der-spek, E. A. De-wit, and N. Litjens, Premature aging of circulating T cells in patients with end-stage renal disease, Kidney Int, vol.80, pp.208-225, 2011.

P. Meier, E. Dayer, P. Ronco, and E. Blanc, Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure, Clin Nephrol, vol.63, pp.8-21, 2005.

P. Meier, D. Golshayan, E. Blanc, M. Pascual, and M. Burnier, Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD, J Am Soc Nephrol, vol.20, pp.1368-84, 2009.

L. S. Dalrymple and A. S. Go, Epidemiology of acute infections among patients with chronic kidney disease, Clin J Am Soc Nephrol, vol.3, pp.1487-93, 2008.

M. J. Sarnak and B. L. Jaber, Mortality caused by sepsis in patients with end-stage renal disease compared with the general population, Kidney Int, vol.58, pp.1758-64, 2000.

M. H. Ghadiani, S. Besharati, N. Mousavinasab, and M. Jalalzadeh, Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients, J Res Med Sci, vol.17, pp.527-560, 2012.

W. I. Bensinger, R. Clift, P. Martin, F. R. Appelbaum, T. Demirer et al., Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation, Blood, vol.88, pp.2794-800, 1996.

K. Koh, A. Sunkara, G. Kang, A. Sooter, D. A. Mulrooney et al., Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes, Biol Blood Marrow Transplant, vol.24, pp.758-64, 2018.

M. Ando, J. Mori, K. Ohashi, H. Akiyama, T. Morito et al., A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT, Bone Marrow Transplant, vol.45, pp.1427-1461, 2010.

J. L. Piñana, D. Valcárcel, R. Martino, P. Barba, E. Moreno et al., Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience, Biol Blood Marrow Transplant, vol.15, pp.21-30, 2009.

E. Meijer, G. J. Boland, and L. F. Verdonck, Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants, Clin Microbiol Rev, vol.16, pp.647-57, 2003.

S. Maury, J. Y. Mary, C. Rabian, M. Schwarzinger, A. Toubert et al., Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients, Br J Haematol, vol.115, pp.630-671, 2001.

S. Servais, E. Lengline, R. Porcher, M. Carmagnat, P. De-latour et al., Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, vol.20, pp.507-524, 2014.

T. N. Small, D. Avigan, B. Dupont, K. Smith, P. Black et al., Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis, Biol Blood Marrow Transplant, vol.3, pp.65-75, 1997.

J. Storek, T. Gooley, R. P. Witherspoon, K. M. Sullivan, and R. Storb, Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts, Am J Hematol, vol.54, pp.131-139, 1997.

C. Stuehler, E. Kuenzli, V. K. Jaeger, V. Baettig, F. Ferracin et al., Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis, J Infect Dis, vol.212, pp.959-67, 2015.

L. J. D'orsogna, M. P. Wright, R. G. Krueger, E. J. Mckinnon, S. I. Buffery et al., Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells, Biol Blood Marrow Transplant, vol.15, pp.795-803, 2009.

M. Edinger, P. Hoffmann, J. Ermann, K. Drago, C. G. Fathman et al., CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation, Nat Med, vol.9, pp.1144-50, 2003.

Q. Li, Z. Zhai, X. Xu, Y. Shen, A. Zhang et al., Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graftversus-host disease following allogeneic haematogenesis stem cell transplantation, Leuk Res, vol.34, pp.1158-68, 2010.

P. Trzonkowski, M. Bieniaszewska, J. Ju?ci?ska, A. Dobyszuk, A. Krzystyniak et al., Firstin-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells, Clin Immunol, vol.133, pp.22-28, 2009.

J. L. Cohen and O. Boyer, The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graftversus-host disease, Curr Opin Immunol, vol.18, pp.580-585, 2006.

R. Powles, S. Singhal, J. Treleaven, S. Kulkarni, C. Horton et al., Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation, Blood, vol.91, pp.3481-3487, 1998.

L. Maggs, F. Kinsella, Y. Chan, S. Eldershaw, D. Murray et al., The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT, Blood Adv, vol.1, pp.1589-97, 2017.

H. T. Kim, A. P. Frederick, D. Andler, E. Cutler, C. Koreth et al., Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome, Biol Blood Marrow Transplant, vol.21, pp.873-80, 2015.

M. Gooptu, H. T. Kim, Y. Chen, W. Rybka, A. Artz et al., Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a DoubleBlind Randomized Controlled Trial, Biol Blood Marrow Transplant, 2018.

D. H. Kim, S. K. Sohn, D. I. Won, N. Y. Lee, J. S. Suh et al., Rapid helper T-cell recovery above 200 x Marrow Transplant, vol.37, pp.1119-1147, 2006.

Y. Sun, F. Meng, M. Han, X. Zhang, L. Yu et al., Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study, Biol Blood Marrow Transplant, vol.21, pp.1117-1143, 2015.

J. Himmelfarb, E. Mcmonagle, S. Freedman, J. Klenzak, E. Mcmenamin et al., Oxidative stress is increased in critically ill patients with acute renal failure, J Am Soc Nephrol, vol.15, pp.2449-56, 2004.

L. Bai, G. Best, W. Xia, L. Peters, K. Wong et al., Expression of Intracellular Reactive Oxygen Species in Hematopoietic Stem Cells Correlates with Time to Neutrophil and Platelet Engraftment in Patients Undergoing Autologous Bone Marrow Transplantation, Biol Blood Marrow Transplant, 2018.

N. Simon, V. Coiteux, B. Bruno, S. Taque, A. Charbonnier et al., Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
URL : https://hal.archives-ouvertes.fr/hal-01741178

, Bull Cancer, vol.104, pp.99-105, 2017.

S. Masouridi-levrat, F. Simonetta, and Y. Chalandon, Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation, Front Immunol, vol.7, p.362, 2016.

S. Faubel, E. C. Lewis, L. Reznikov, D. Ljubanovic, T. S. Hoke et al., Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney, J Pharmacol Exp Ther, vol.322, pp.8-15, 2007.

M. L. Kielar, R. John, M. Bennett, J. A. Richardson, J. M. Shelton et al., Maladaptive role of IL-6 in ischemic acute renal failure, J Am Soc Nephrol, vol.16, pp.3315-3340, 2005.

D. N. Grigoryev, M. Liu, H. T. Hassoun, C. Cheadle, K. C. Barnes et al., The local and systemic inflammatory transcriptome after acute kidney injury, J Am Soc Nephrol, vol.19, pp.547-58, 2008.

T. S. Hoke, I. S. Douglas, C. L. Klein, Z. He, W. Fang et al., Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury, J Am Soc Nephrol, vol.18, pp.155-64, 2007.

A. Dursun, B. Altmann, C. Ahuja, N. He, Z. Bhargava et al., Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy, Nephrol Dial Transplant, vol.27, pp.4339-4386, 2012.

C. L. Klein, T. S. Hoke, W. Fang, C. J. Altmann, I. S. Douglas et al., Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy, Kidney Int, vol.74, pp.901-910, 2008.

K. J. Kelly, Distant effects of experimental renal ischemia/reperfusion injury, J Am Soc Nephrol, vol.14, pp.1549-58, 2003.

F. Golab, M. Kadkhodaee, M. Zahmatkesh, M. Hedayati, H. Arab et al., Ischemic and non-ischemic acute kidney injury cause hepatic damage, Kidney Int, vol.75, pp.783-92, 2009.

K. Singbartl, J. V. Bishop, X. Wen, R. Murugan, S. Chandra et al., Differential effects of kidney-lung cross-talk during acute kidney injury and bacterial pneumonia, Kidney Int, vol.80, pp.633-677, 2011.

A. Zarbock, M. Schmolke, T. Spieker, K. Jurk, H. Van-aken et al., Acute uremia but not renal inflammation attenuates aseptic acute lung injury: a critical role for uremic neutrophils, J Am Soc Nephrol, vol.17, pp.3124-3155, 2006.

K. Singbartl, L. Miller, V. Ruiz-velasco, and J. A. Kellum, Reversal of Acute Kidney Injury-Induced Neutrophil Dysfunction: A Critical Role for Resistin, Crit Care Med, vol.44, pp.492-501, 2016.

R. C. Silva, M. A. Landgraf, M. Corrêa-costa, P. Semedo, M. A. Cenedeze et al., Acute kidney injury reduces phagocytic and microbicidal capacities of alveolar macrophages, Cell Physiol Biochem, vol.31, pp.179-88, 2013.

D. F. Florescu, A. C. Kalil, F. Qiu, C. M. Schmidt, and U. Sandkovsky, What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A metaanalysis, Am J Transplant, vol.13, pp.2601-2611, 2013.

B. Foley, S. Cooley, M. R. Verneris, J. Curtsinger, X. Luo et al., NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions, Blood, vol.118, pp.2784-92, 2011.

E. Hoste, S. I. Blot, N. H. Lameire, R. C. Vanholder, D. Bacquer et al., Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy, J Am Soc Nephrol, vol.15, pp.454-62, 2004.

A. Bernier-jean, W. Beaubien-souligny, T. Ducruet, A. Duca, M. Albert et al., Risk of de novo infection following acute kidney injury: A retrospective cohort study, J Crit Care, vol.48, pp.9-14, 2018.

T. Lai, C. Wang, S. Pan, T. Huang, M. Lin et al., Risk of developing severe sepsis after acute kidney injury: a population-based cohort study, Crit Care, vol.17, p.231, 2013.

K. Soto, P. Campos, I. Pinto, B. Rodrigues, F. Frade et al., The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury, Kidney Int, vol.90, pp.1090-1099, 2016.

M. Ando, K. Ohashi, H. Akiyama, H. Sakamaki, T. Morito et al., Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors, Nephrol Dial Transplant, vol.25, pp.278-82, 2010.

T. Jo, Y. Arai, T. Kondo, T. Kitano, M. Hishizawa et al., Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute, Biol Blood Marrow Transplant, vol.23, pp.2159-65, 2017.

S. Hingorani, E. Pao, P. Stevenson, G. Schoch, B. L. Laskin et al., Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study, Clin J Am Soc Nephrol, 2018.

W. Zhou, R. Sultana, C. Diong, Y. Goh, S. Gopalakrishnan et al., Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population, Clin Transplant, p.31, 2017.

C. R. Parikh, B. M. Sandmaier, R. F. Storb, K. G. Blume, F. Sahebi et al., Acute renal failure after nonmyeloablative hematopoietic cell transplantation, J Am Soc Nephrol, vol.15, pp.1868-76, 2004.

M. Haase, P. Devarajan, A. Haase-fielitz, R. Bellomo, D. N. Cruz et al., The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies, J Am Coll Cardiol, vol.57, pp.1752-61, 2011.

Y. Kim, Y. S. Cho, D. Kym, J. Yoon, H. Yim et al., Diagnostic performance of plasma and urine neutrophil gelatinase-associated lipocalin, cystatin C, and creatinine for acute kidney injury in burn patients: A prospective cohort study, PLoS ONE, vol.13, p.199600, 2018.

K. Wang, S. Xie, K. Xiao, P. Yan, W. He et al., Biomarkers of Sepsis-Induced Acute Kidney Injury, Biomed Res Int, p.6937947, 2018.

M. Taghizadeh-ghehi, A. Sarayani, A. Ashouri, S. Ataei, A. Moslehi et al., Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients, Ren Fail, vol.37, pp.994-1002, 2015.